DISCLAIMER: This product is strictly for research use only. It is meant solely for laboratory testing and in vitro studies-not for use in or on humans or animals. All details provided on this site are for educational purposes. This item is not intended to be used as a drug, supplement, or cosmetic, and must not be misrepresented as such.
GLP-2 T *COMING SOON*
GLP-2 T is a synthetic peptide that activates both GLP-1 and GIP receptors—two incretin pathways involved in blood sugar regulation and appetite control. By enhancing insulin secretion, reducing glucagon, and promoting satiety, it supports significant weight loss and improved glucose metabolism. It is FDA-approved for type 2 diabetes and is widely studied for its powerful effects on metabolic health.
Variant: 25mg
Quantity: 1
Currently unavailable. Please check back soon or contact us for more information.
Third-Party Verified Purity
Each batch is tested and certified to meet or exceed 99% purity standards.
Made in the USA
Produced in United States WHO/GMP and ISO 9001:2015 certified facilities.
Rigorous Quality Control
Double-tested to ensure the highest quality for the most effective research.
What is GLP-2 T *COMING SOON*?
GLP-2 T is a synthetic peptide‑based medication that functions as a first‑in‑class dual agonist of the glucose‑dependent insulinotropic polypeptide (GIP) and glucagon‑like peptide‑1 (GLP‑1) receptors, two naturally occurring incretin hormones involved in metabolic regulation. By engaging both GIP and GLP‑1 pathways, GLP-2 T enhances glucose‑dependent insulin secretion, suppresses glucagon release, slows gastric emptying, and increases satiety, resulting in improved blood sugar control and reduced appetite. It is FDA‑approved for the treatment of type 2 diabetes and chronic weight management, and clinical research has shown substantial reductions in blood glucose levels and body weight compared with traditional single‑pathway therapies.
Potential Benefits Shown in Studies
- Supports significant weight loss through appetite suppression and delayed gastric emptying
- Improves blood sugar control by enhancing glucose-dependent insulin secretion
- Reduces fasting and post-meal glucose levels
- Lowers HbA1c more effectively than GLP-1 agonists alone
- Promotes greater satiety and reduced caloric intake
- May improve lipid profiles and cardiometabolic markers
- Combines dual incretin activity (GIP + GLP-1) for enhanced metabolic impact
- FDA-approved for type 2 diabetes and obesity-related weight management
Mechanisms of Action
- GLP-1 Receptor Agonism: Increases insulin secretion, reduces glucagon, slows gastric emptying, and promotes satiety
- GIP Receptor Agonism: Enhances insulin sensitivity and complements GLP-1 effects on energy balance
- Dual Incretin Effect: Combines GLP-1 and GIP pathways for amplified metabolic response
- Appetite & Satiety Regulation: Acts on the hypothalamus to reduce hunger and increase fullness
- Glycemic Control: Lowers both fasting and postprandial blood glucose by mimicking natural gut hormone responses
Molecular Structure of GLP-2 T *COMING SOON*
Sequence
His-Ala-Glu-Gly-Thr-Phe-Thr-Ser-Asp-Tyr-Ser-Ile-Ala-Met-Glu-Glu-Glu-Ala-Val-Arg-Leu-Phe-Ile-Glu-Trp-Leu-Lys-Asn-Gly-Gly-Pro-Ser-Ser-Gly-Ala-Pro-Pro-Pro-Ser-Lys-Lys-γGlu-2xC16 (palmitoyl) diacid
Molecular Properties
- The first 20 amino acids are based on the native GIP sequence
- Modifications throughout the sequence improve GLP-1 receptor activity
- A C20 fatty diacid (two C16 palmitic acid chains) is attached via a γ‑glutamic acid (γGlu) linker to promote albumin binding and extend half-life
- The full molecule is 39 amino acids long, plus the lipidated tail
GLP-2 T *COMING SOON* Research Highlights
Studies have been shown that GLP-2 T reduces weight in obese adults
Source: Pubmed
Studies have shown that GLP-2 T helps with people who have type 2 diabetes
Source: PubMed
